Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure

M J Sullivan1, B D Duscha, H Klitgaard

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

Insights

Chronic heart failure (CHF) significantly alters skeletal muscle myosin heavy chain (MHC) isoform expression, with reduced MHC type I and increased MHC type IIx. These changes may indicate a specific myopathy beyond deconditioning in CHF patients.

Area of Science:

  • Cardiology
  • Skeletal Muscle Physiology
  • Biochemistry

Background:

  • Skeletal muscle alterations are observed in chronic heart failure (CHF).
  • Myosin heavy chain (MHC) isoforms are key determinants of muscle fiber function.
  • Understanding MHC isoform changes in CHF is crucial for comprehending exercise intolerance.

Purpose of the Study:

  • To investigate alterations in MHC isoform composition in the vastus lateralis skeletal muscle of patients with CHF.
  • To correlate MHC isoform expression with exercise capacity (peak oxygen consumption).

Main Methods:

  • Biopsies of vastus lateralis muscle were obtained from nine male patients with class II-III CHF and nine age-matched healthy males.
  • Relative content of MHC isoforms (I, IIa, IIx) was quantified using gel electrophoresis.
  • Expression levels were compared between CHF patients and normal controls.

Main Results:

  • CHF patients exhibited significantly lower relative content of MHC type I compared to normal controls (24% vs 48.4%).
  • CHF patients showed a higher relative content of MHC type IIx than normal controls (20% vs 6.5%).
  • No significant difference was found in MHC type IIa content between groups.
  • Three out of nine CHF patients had undetectable MHC type I.
  • Relative MHC type I expression in CHF patients correlated positively with peak oxygen consumption (r=0.70).

Conclusions:

  • Significant alterations in MHC isoform expression, specifically a reduction in MHC type I and an increase in MHC type IIx, are present in skeletal muscle of CHF patients.
  • These changes suggest a potential specific skeletal muscle myopathy in CHF, not solely attributable to deconditioning.
  • MHC isoform alterations may contribute to impaired skeletal muscle contractile function and reduced exercise performance in CHF.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...